208,077.7 713.9 Operating expenses 6,802.3 23.3 12,257.5 42.1 15,095.5 51.8 Depreciation and Amortization 35,526.0 121.9 38,421.0 131.8 38,426.6 131.8 Financial Cost - - 7.3 0.0 156.4 0.5 Net Profit 117,967.8

. 3. Performance of the Company Operating Results The Company reported a net profit of Baht 3,345 million compared to loss of Baht 1,810 million last year as explained above. The consolidated post net

their operating costs, transfer fee of drug registration to be paid to government agencies that should be responsible by seller บร ิษัท อ ินเตอร ์ฟารม์า จาํกัด (มหาชน) เลขท ี / อาคารไอทเีอฟ ชัน ถนนสีลม

parent 63.6% 60.0% 63.0% 58.9% 61.2% Remark: * EBITDA = Earnings before interest, taxes, depreciation and amortization - non-operating income / (expense) ** Normalized net profit = Net profit – unrealized

disposed percentage, divided by net profit of the Company Calculation cannot be made given each of the Company, UAB and SBM has operating losses n.a. 3. Total consideration Total consideration paid or

Bangchak Corporation Plc. I 3 Executive Summary Summary of the Company and its subsidiaries’ operating results for the quarter ended 30th September 2019 Unit: THB Million Q3/2019 Q2/2019 QoQ Q3/2018 YoY

accurately on the matter of substance concerning to the financial position, operating result and cash flow of the Company. 13. Other Information that may significantly affect the decision of the Company’s

Part 1; (2) Filing of the Registration Statement for an Offer for Sale of Depositary Receipts under Part 2; (3) Ongoing Disclosure of Information on Financial Position and Operating Results of the Issuer

index calculation and guidelines for managing the fund in case of such circumstances. (2) Information on the price or the operating results of the goods or the underlying during at least the past three

asset of the Company is negative. 2. Net Operating Profits Criteria Cannot be calculated since the net profit of the Company is negative. 3. Total Value of Consideration Criteria Total value of